Literature DB >> 956039

Isolation of a new antibiotic 333-25, related to antibiotic EM 49. (Studies on antibiotics from the genus Bacillus. XI).

J Shoji, H Hinoo, Y Wakisaka, K Koizumi, M Mayama.   

Abstract

A new antibiotic, 333-25, active against Gram-positive and Gram-negative bacteria, was isolated from the culture broth of Bacillus circulans 333-25. The antibiotic is a basic acylpeptide containing 2,4-diaminobutyric acid (5), leucine (2), phenylalanine (1) and a fatty acid. It is closely related to antibiotic EM 49, but can be differentiated by chromatographic behaviour.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956039     DOI: 10.7164/antibiotics.29.516

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

Review 1.  Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.

Authors:  Pamela Brown; Michael J Dawson
Journal:  J Antibiot (Tokyo)       Date:  2017-01-11       Impact factor: 2.649

Review 2.  Rediscovering the octapeptins.

Authors:  Tony Velkov; Kade D Roberts; Jian Li
Journal:  Nat Prod Rep       Date:  2017-03-17       Impact factor: 13.423

3.  Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes.

Authors:  Mei-Ling Han; Hsin-Hui Shen; Karl A Hansford; Elena K Schneider; Sivashangarie Sivanesan; Kade D Roberts; Philip E Thompson; Anton P Le Brun; Yan Zhu; Marc-Antoine Sani; Frances Separovic; Mark A T Blaskovich; Mark A Baker; Samuel M Moskowitz; Matthew A Cooper; Jian Li; Tony Velkov
Journal:  ACS Infect Dis       Date:  2017-07-11       Impact factor: 5.084

4.  Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.

Authors:  Elena K Schneider-Futschik; Olivia K A Paulin; Daniel Hoyer; Kade D Roberts; James Ziogas; Mark A Baker; John Karas; Jian Li; Tony Velkov
Journal:  ACS Infect Dis       Date:  2018-04-02       Impact factor: 5.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.